Es. Louwerse et al., URINARY-EXCRETION OF LEAD AND MERCURY AFTER ORAL-ADMINISTRATION OF MESO-2,3-DIMERCAPTOSUCCINIC ACID IN PATIENTS WITH MOTOR-NEURON DISEASE, International archives of occupational and environmental health, 67(2), 1995, pp. 135-138
Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA)
are progressive neurodegenerative disorders involving motor neurones.
The aetiology of the non-familial forms is still unknown but it has be
en suggested that long-term exposure to heavy metals such as lead and
mercury may play a role in the pathogenesis of these diseases. In 53 p
atients suffering from ALS (n = 42) and SMA (n = 9) the oral administr
ation of dimercaptosuccinic acid (DMSA, 20 mg/kg) did not result in a
greater mobilization of lead and mercury from peripheral depots than i
n control subjects. Although it cannot be excluded that the amount of
lead or mercury excreted after DMSA administration may not be a reflec
tion of the amount accumulated in the motor neurones, this study does
not provide support for the hypothesis that heavy metals play a signif
icant role in the occurrence of motor neurone diseases.